CoreWeave concentration of 2026 revenue
Company: Core Scientific
The claim, verbatim
By 2026, CoreWeave-related revenue is projected to be about 95% of Core Scientific's colocation revenue and about 76% of its total projected revenue.
Source (primary)
core-scientific 8-K exhibit (ef20056907_ex99-1.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-09-28)Live source ↗
Quote: “By 2026E, CoreWeave-related revenue is projected to constitute ~95% of Core Scientific's Colocation revenue and ~76% of its total projected revenue”
How we checked this
Checked on September 30, 2026. The cited source supports every part of this claim.
The document states both the ~95% colocation share and the ~76% total revenue share for 2026E.
Confirmed in the source:
- By 2026, CoreWeave-related revenue is projected to be about 95% of Core Scientific's colocation revenue
- By 2026, CoreWeave-related revenue is projected to be about 76% of Core Scientific's total projected revenue
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000114036125037969/ef20056907_ex99-1.htm) in full (41,468 characters, retrieved September 28, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (ef20056907_ex99-1.htm)
Quote: “By 2026E, CoreWeave-related revenue is projected to constitute ~95% of Core Scientific's Colocation revenue and ~76% of its total projected revenue”